Titlebook: Oncologic Therapies; Everett E. Vokes,Harvey M. Golomb Book 2003Latest edition Springer-Verlag Berlin Heidelberg 2003 Cancer therapy.Chemo

Estimable

prodrome

Principles of Cancer Immunotherapymmunosuppressive drugs and AIDS has revealed that an intact immune system is required for protection against many cancers, particularly those with a viral origin. Animal models have demonstrated the powerful capability of an appropriately activated cellular immune response to reject established tumo

Bureaucracy

Ethics and the Development of New Oncologic Therapies: Informed Consent, Equipoise, and the Randomize scrutiny. Indeed, it is on the randomized trial process in . clinical research that much of this scrutiny has centered. The overall informed consent process in phase III trials and, more specifically, how disclosure to potential subjects regarding the randomization process itself should be conduct

SLUMP

Diagnosis and Management of Oncologic Emergenciescommon oncologic emergencies. Because of the systemic nature of cancer, these emergencies often affect organ systems remote from the original cancer, making diagnosis challenging. Given the long natural history of many advanced cancers, the successful diagnosis and management of these emergencies ma

提升

predict

Hematopoietic Growth Factorsdemonstrated the ability to lessen the severity of chemotherapy-induced cytopenias and have contributed to the preservation of dose intensity in standard chemotherapy regimens. Commercially available colony stimulating factors (CSFs) in the United States include G-CSF, GM-CSF, epoetin alfa, darbepoe

裹住

Pain Managementmage” [.]. Approximately 80% of patients with cancer will experience significant pain as a result of their disease and/or its treatment [.]. Optimal management of pain at all stages of the therapeutic pathway will reduce the suffering associated with cancer, enhancing quality of life and physiologic

十字架

Chemotherapy-Induced Nausea and Vomitings beginning cytotoxic chemotherapy. 5-HT. antagonists have decreased the frequency of postchemotherapy vomiting. However, emesis remains a problem for a significant minority of patients. In addition, nausea continues to be a formidable challenge despite the better control of vomiting with current tr

pulmonary-edema

钻孔